Philippines - anglais - FDA (Food And Drug Administration)

pnf pharmaceutical, inc.; distributor: duopharma trade phils., inc. - insulin human (rdna) - suspension for injection (im/sc) - 100 iu/ml (100% isophane insulin human)

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: pnf pharmaceutical, inc; distributor: jackpharma inc - insulin human (rdna) - suspension for injection (im/sc) (100% isophane insulin human) - 100 iu/ml

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: pnf pharmaceutical, inc; distributor: mega lifesciences limited inc - insulin human (rdna) - suspension for injection (im/sc) (100% isophane insulin human) - 100 iu/ml

États-Unis - anglais - NLM (National Library of Medicine)

tya pharmaceuticals - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - important: . do not change the type of insulin you use unless told to do so by your healthcare provider. the amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin. know your insulin make sure that you know the type and strength of insulin that is prescribed for you. read the patient information leaflet that comes with novolin n before you start taking it and each time you get a refill. there may be new information. this leaflet does not take the place of talking with your healthcare provider about your diabetes or your treatment. make sure you know how to manage your diabetes. ask your healthcare provider if you have any questions about managing your diabetes. ® what is novolin n? ® novolin n is a man-made insulin (recombinant dna origin) nph, human insulin isophane suspension that is structurally identical to the insulin produced by the

États-Unis - anglais - NLM (National Library of Medicine)

novo nordisk - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - novolin n is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. novolin n is contraindicated: risk summary available data from published studies over decades have not established an association with human insulin use during pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes (see data). there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations). animal reproduction studies were not performed. the estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a hba1c >7 and has been reported to be as high as 20-25% in women with a hba1c >10. the estimated background risk of miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations diseas

Israël - anglais - Ministry of Health

novo nordisk ltd., israel - insulin (human) - solution for injection - insulin (human) 100 u/ml - insulin (human) - insulin (human) - actrapid is indicated for treatment of diabetes mellitus.

Israël - anglais - Ministry of Health

novo nordisk ltd., israel - insulin (human) - solution for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - therapeutic indicationsactrapid is indicated for treatment of diabetes mellitus.

Israël - anglais - Ministry of Health

novo nordisk ltd., israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - insulatard is indicated for treatment of diabetes mellitus

Israël - anglais - Ministry of Health

novo nordisk ltd., israel - insulin (human) - suspension for injection - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - insulatard is indicated for treatment of diabetes mellitus.

Philippines - anglais - FDA (Food And Drug Administration)

pnf pharmaceutical, inc.; distributor: aristo pharma philippines, inc. - isophane insulin human - suspension for injection (im/sc) - 100 iu/ml (100% isophane insulin human)